A new study has found that breast cancer spreads through the body more efficiently while patients are sleeping.
The surprising finding, revealed in a study led by researchers at ETH Zurich, could change the way cancer is diagnosed and treated in future.
Breast cancer is one of the most common forms of cancer, according to the World Health Organization (WHO). Each year, around 2.3 million people worldwide contract the disease. If doctors detect breast cancer early enough, patients usually respond well to treatment.
However, things become much more difficult if the cancer has already metastasised.
Metastasis is when circulating cancer cells break away from the original tumour, travel through the body via blood vessels and form new tumours in other organs. In other words, it is when the cancer spreads, which can make it much more difficult to treat.
In the past, cancer research has not paid much attention to the question of when cancer spreads. Researchers previously assumed that tumours release cells into the body continuously – so spreading can happen at any time.
However, the new study by researchers at ETH Zurich, the University Hospital Basel and the University of Basel has concluded that circulating cancer cells that later form metastases mainly arise during the sleep phase of the patients.
The results of the study have just been published in the journal Nature.
Why is this the case?
The researchers say that circadian rhythm-regulated hormones control metastasis of the tumours.
‘When the affected person is asleep, the tumour awakens,’ summarises study leader Nicola Aceto, professor of molecular oncology at ETH Zurich.
During their study, which included 30 female cancer patients and mouse models, the researchers found that the tumour generates more circulating cells when the organism is asleep.
Cells that leave the tumour at night also divide more quickly and therefore have a higher potential to form metastases, compared to circulating cells that leave the tumour during the day.
‘Our research shows that the escape of circulating cancer cells from the original tumour is controlled by hormones such as melatonin, which determine our rhythms of day and night,’ adds Zoi Diamantopoulou, the study’s lead author and a postdoctoral researcher at ETH Zurich.
Adjusting therapies to the tumour
Another interesting conclusion of the study is that the time in which tumour or blood samples are taken for diagnosis may influence the findings of oncologists.
It was an accidental finding that first put the researchers on the right track.
‘Some of my colleagues work early in the morning or late in the evening; sometimes they’ll also analyse blood at unusual hours,’ says Nicola.
The scientists were surprised to find that samples taken at different times of the day had very different levels of circulating cancer cells.
Another clue was the surprisingly high number of cancer cells found per unit of blood in mice compared to humans. The reason was that as nocturnal animals, mice sleep during the day, which is when scientists collect most of their samples.
‘In our view, these findings may indicate the need for healthcare professionals to systematically record the time at which they perform biopsies,’ Nicola says. ‘It may help to make the data truly comparable.’
The researchers’ next step will be to figure out how these findings can be incorporated into existing cancer treatments to optimise therapies.
As part of further studies with patients, Professor Nicola Aceto wants to investigate whether different types of cancer behave similarly to breast cancer and whether existing therapies can be made more successful if patients are treated at different times.
Do you have a story to share?
Get in touch by emailing [email protected]
Source: Read Full Article